CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression

Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)

Shigeru Tsuchiya, Michiko Yamabe, Yoshiko Yamaguchi et al. · International Journal of Cancer · 1980 · 2.3K citations

Life Sciences, Cell Biology, Immunology +14

Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia

Robert E. Gallagher, Steven Collins, José M. Trujillo et al. · Blood · 1979 · 917 citations · Full text

Medicine, Cell Biology, Hematology +13

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

Stefan Stein, Marion Ott, Stephan Schultze‐Strasser et al. · Nature Medicine · 2010 · 784 citations

Medicine, Genetics, Molecular Genetics +16

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

Anders Österborg, Martin J.S. Dyer, Donald Bunjes et al. · Journal of Clinical Oncology · 1997 · 518 citations

Medicine, Oncology, Pharmacology +16

Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines

Kazuhiro Morishita, Diana S. Parker, Michael L. Mucenski et al. · Cell · 1988 · 420 citations

Life Sciences, Immunology, Molecular Biology +12